ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 1 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,376 | +49.3% | 485,202 | +43.1% | 0.06% | +74.3% |
| Q2 2023 | $4,272 | -34.4% | 339,064 | -32.0% | 0.04% | -35.2% |
| Q1 2023 | $6,511 | +783.4% | 498,919 | +1094.3% | 0.05% | +390.9% |
| Q4 2022 | $737 | -99.9% | 41,776 | -28.6% | 0.01% | -8.3% |
| Q3 2022 | $891,000 | -22.3% | 58,484 | -24.3% | 0.01% | -14.3% |
| Q2 2022 | $1,146,000 | -65.8% | 77,291 | -48.1% | 0.01% | -66.7% |
| Q1 2022 | $3,353,000 | +111.8% | 148,873 | +73.5% | 0.04% | +162.5% |
| Q4 2021 | $1,583,000 | -49.3% | 85,806 | -63.3% | 0.02% | -61.9% |
| Q3 2021 | $3,123,000 | +101.4% | 233,563 | +126.1% | 0.04% | +82.6% |
| Q1 2021 | $1,551,000 | -54.7% | 103,305 | -56.4% | 0.02% | -30.3% |
| Q4 2020 | $3,423,000 | +613.1% | 236,858 | +301.8% | 0.03% | +230.0% |
| Q3 2020 | $480,000 | +42.9% | 58,946 | +18.7% | 0.01% | +11.1% |
| Q2 2020 | $336,000 | -53.8% | 49,654 | -33.0% | 0.01% | -35.7% |
| Q4 2019 | $727,000 | – | 74,101 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GLENHILL ADVISORS LLC | 10,507,149 | $138,799,000 | 8.42% |
| Tamarack Advisers, LP | 1,650,000 | $21,797,000 | 7.63% |
| Blue Harbour Group | 10,759,695 | $142,136,000 | 4.78% |
| BROADVIEW ADVISORS LLC | 1,095,800 | $14,476,000 | 2.08% |
| Rovida Advisors Inc. | 752,400 | $9,939,000 | 2.04% |
| Adirondack Research & Management Inc. | 361,259 | $4,772,000 | 1.73% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 1,104,400 | $14,589,000 | 1.70% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 14,401,161 | $190,239,000 | 1.62% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 5,077,304 | $67,071,000 | 1.30% |
| Iguana Healthcare Management, LLC | 250,000 | $3,303,000 | 1.21% |